HIMS Stock Just Exploded 40%, And the Company That Nearly Destroyed It Is Now Its Savior The Novo Nordisk–Hims & Hers story has every twist of a Wall Street thriller. Here's the full breakdown. The Short Version (For the "Just Tell Me What Happened" Crowd) Most financial headlines are written like legal documents. So before we dive deep, here's the human version: Hims & Hers Health (NYSE: HIMS), the telehealth company behind those sleek ads for hair loss, ED meds, and yes, weight-loss drugs, just got a massive lifeline. The company that was literally suing them last month? Novo Nordisk. The maker of Wegovy and Ozempic. And now? They're apparently… partners again. Hims stock surged 39% in after-hours trading Friday after Bloomberg reported that Novo Nordisk plans to sell its weight-loss drugs through Hims' telehealth platform, ending the legal dispute, including a patent infringement lawsuit filed by Novo just weeks ago. That's...
Pocket Democracy is a premier financial research platform, Its mission is to help small business investors. The ultimate resource for personal finance, small business owners, legal tips, and insurance coverage. Simplify your financial life and protect what matters.